Home > Qtrly Results > BAFNA PHARMACEUTICALS

BAFNA PHARMACEUTICALS
Quarterly Results Analysis [Dec2025]

AD     Remove this Ad

BAFNA PHARMACEUTICALS Quarterly Results

Standalone Dec2025
UnAudited
Sep2025
UnAudited
Jun2025
UnAudited
Mar2025
UnAudited
Dec2024
UnAudited
Sep2024
UnAudited
Jun2024
UnAudited
Mar2024
UnAudited
Revenues ₹38 Cr ₹35 Cr ₹35 Cr ₹39 Cr ₹33 Cr ₹40 Cr ₹33 Cr ₹41 Cr
Expenses ₹35 Cr ₹31 Cr ₹30 Cr ₹36 Cr ₹30 Cr ₹37 Cr ₹32 Cr ₹39 Cr
Operating Income ₹3 Cr ₹4 Cr ₹5 Cr ₹3 Cr ₹3 Cr ₹4 Cr ₹1 Cr ₹3 Cr
Other Income ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹0 Cr ₹1 Cr ₹1 Cr ₹1 Cr
Interest ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr
Depreciation ₹2 Cr ₹1 Cr ₹1 Cr ₹0 Cr ₹2 Cr ₹2 Cr ₹1 Cr ₹1 Cr
Profit Before Tax ₹2 Cr ₹3 Cr ₹3 Cr ₹1 Cr ₹1 Cr ₹3 Cr ₹-1 Cr ₹1 Cr
Profit After Tax ₹2 Cr ₹3 Cr ₹3 Cr ₹1 Cr ₹1 Cr ₹3 Cr ₹-1 Cr ₹1 Cr
EPS ₹0.78 ₹1.32 ₹1.43 ₹0.55 ₹0.40 ₹1.11 ₹-0.31 ₹0.62
Industry Peers & Returns1W1M1Y
BAFNA PHARMACEUTICALS -6.2% -9.7% 52.5%
SUN PHARMACEUTICAL INDUSTRIES -0.5% 1.8% -2%
DIVIS LABORATORIES -0.3% -1.3% 4%
CIPLA 1% -3% -8.7%
TORRENT PHARMACEUTICALS 4.4% 6% 27.7%
DR REDDYS LABORATORIES 1.1% 8% 3.8%
MANKIND PHARMA 0.5% -4.3% -17.8%
ZYDUS LIFESCIENCES 2.6% 4.9% -6.2%
LUPIN 0.7% 2% 1.4%

BAFNA PHARMACEUTICALS Quarterly Revenues

Revenues
Q-o-Q

7.95 %

Y-o-Y

15.36 %

Quarters Revenues % Change
Dec2025 ₹38 Cr
7.95
Sep2025 ₹35 Cr
2.44
Jun2025 ₹35 Cr
-11.36
Mar2025 ₹39 Cr
17.69
Dec2024 ₹33 Cr
-17.69
Sep2024 ₹40 Cr
21.14
Jun2024 ₹33 Cr
-19.60
Mar2024 ₹41 Cr -

BAFNA PHARMACEUTICALS Quarterly Operating Profit

Operating Profit
Q-o-Q

-28.79 %

Y-o-Y

-0.39 %

Quarters Operating Profit % Change
Dec2025 ₹3 Cr
-28.79
Sep2025 ₹4 Cr
-15.51
Jun2025 ₹5 Cr
62.83
Mar2025 ₹3 Cr
1.67
Dec2024 ₹3 Cr
-19.25
Sep2024 ₹4 Cr
213.13
Jun2024 ₹1 Cr
-58.07
Mar2024 ₹3 Cr -
Operating Margins
Q-o-Q

-34.02 %

Y-o-Y

-13.65 %

Quarters Operating Margin% % Change
Dec2025 7.97%
-34.02
Sep2025 12.08%
-17.49
Jun2025 14.64%
83.69
Mar2025 7.97%
-13.65
Dec2024 9.23%
-1.81
Sep2024 9.4%
158.24
Jun2024 3.64%
-47.85
Mar2024 6.98% -

BAFNA PHARMACEUTICALS Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

-41.23 %

Y-o-Y

93.78 %

Quarters Profit After Tax % Change
Dec2025 ₹2 Cr
-41.23
Sep2025 ₹3 Cr
-7.79
Jun2025 ₹3 Cr
158.38
Mar2025 ₹1 Cr
38.40
Dec2024 ₹1 Cr
-63.76
Sep2024 ₹3 Cr
Positive
Jun2024 ₹-1 Cr
Negative
Mar2024 ₹1 Cr -
PAT Margins
Q-o-Q

-45.52 %

Y-o-Y

67.83 %

Quarters PAT Margin(%) % Change
Dec2025 4.8 %
-45.52
Sep2025 8.81 %
-10.01
Jun2025 9.79 %
191.37
Mar2025 3.36 %
17.48
Dec2024 2.86 %
-55.93
Sep2024 6.49 %
Positive
Jun2024 -2.17 %
Negative
Mar2024 3.52 % -

BAFNA PHARMACEUTICALS Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

-40.91 %

Y-o-Y

95.00 %

Quarters EPS % Change
Dec2025 ₹0.78
-40.91
Sep2025 ₹1.32
-7.69
Jun2025 ₹1.43
160.00
Mar2025 ₹0.55
37.50
Dec2024 ₹0.4
-63.96
Sep2024 ₹1.11
Positive
Jun2024 ₹-0.31
Negative
Mar2024 ₹0.62 -

You may also like the below Video Courses